QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
NASDAQ:HCWB

HCW Biologics - HCWB Stock Forecast, Price & News

$2.04
-0.03 (-1.45%)
(As of 12/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$2.02
$2.10
50-Day Range
$2.07
$2.42
52-Week Range
$1.76
$3.32
Volume
9,500 shs
Average Volume
34,214 shs
Market Capitalization
$73.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00

HCW Biologics MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
194.1% Upside
$6.00 Price Target
Short Interest
Healthy
0.10% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$89,130 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.16 out of 5 stars

Medical Sector

630th out of 1,023 stocks

Pharmaceutical Preparations Industry

308th out of 501 stocks

HCWB stock logo

About HCW Biologics (NASDAQ:HCWB) Stock

HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.

Receive HCWB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HCW Biologics and its competitors with MarketBeat's FREE daily newsletter.

HCWB Stock News Headlines

HCW Biologics (NASDAQ:HCWB) Shares Up 1.6%
HCW Biologics Inc. (HCWB)
HCW Biologics, Inc. (HCWB)
HCW Biologics Inc. Common Stock (HCWB)
HCW Leaps on Publishing New Work
See More Headlines
Receive HCWB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HCW Biologics and its competitors with MarketBeat's FREE daily newsletter.

HCWB Company Calendar

Today
12/06/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
4/04/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HCWB
Employees
44
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$6.00
High Stock Price Forecast
$8.00
Low Stock Price Forecast
$4.00
Forecasted Upside/Downside
+194.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-12,860,000.00
Pretax Margin
-354.28%

Debt

Sales & Book Value

Annual Sales
$4.10 million
Book Value
$1.43 per share

Miscellaneous

Free Float
20,088,000
Market Cap
$73.18 million
Optionable
Not Optionable
Beta
0.94

Key Executives

  • Dr. Hing C. Wong Ph.D. (Age 68)
    Founder, CEO, Director & Sec.
    Comp: $510.6k
  • Ms. Rebecca Byam CPA (Age 66)
    M.B.A., Chief Financial Officer
    Comp: $357.5k
  • Dr. Peter Rhode Ph.D. (Age 64)
    Chief Scientific Officer & VP of Clinical Operations
    Comp: $236.21k
  • Ms. Nicole Valdivieso Esq.
    VP of Legal Affairs
  • Ms. Raquel Diaz M.S.
    Director of HR
  • Mr. Lee D. Flowers (Age 76)
    Sr. VP of Bus. Devel.













HCWB Stock - Frequently Asked Questions

Should I buy or sell HCW Biologics stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for HCW Biologics in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HCWB shares.
View HCWB analyst ratings
or view top-rated stocks.

What is HCW Biologics' stock price forecast for 2023?

2 equities research analysts have issued 12 month target prices for HCW Biologics' shares. Their HCWB share price forecasts range from $4.00 to $8.00. On average, they predict the company's share price to reach $6.00 in the next twelve months. This suggests a possible upside of 191.3% from the stock's current price.
View analysts price targets for HCWB
or view top-rated stocks among Wall Street analysts.

How have HCWB shares performed in 2022?

HCW Biologics' stock was trading at $2.32 at the beginning of 2022. Since then, HCWB shares have decreased by 11.2% and is now trading at $2.06.
View the best growth stocks for 2022 here
.

Are investors shorting HCW Biologics?

HCW Biologics saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 14,200 shares, an increase of 23.5% from the October 31st total of 11,500 shares. Based on an average trading volume of 25,100 shares, the days-to-cover ratio is currently 0.6 days. Approximately 0.1% of the company's shares are sold short.
View HCW Biologics' Short Interest
.

When is HCW Biologics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 4th 2023.
View our HCWB earnings forecast
.

When did HCW Biologics IPO?

(HCWB) raised $45 million in an initial public offering on Tuesday, July 20th 2021. The company issued 5,600,000 shares at $8.00 per share. EF Hutton served as the underwriter for the IPO and Revere Securities was co-manager.

What is HCW Biologics' stock symbol?

HCW Biologics trades on the NASDAQ under the ticker symbol "HCWB."

Who are HCW Biologics' major shareholders?

HCW Biologics' stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (0.27%). Insiders that own company stock include Gary M Winer, Hing C Wong, Jin-An Jiao, Rebecca Byam and Rick S Greene.
View institutional ownership trends
.

How do I buy shares of HCW Biologics?

Shares of HCWB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is HCW Biologics' stock price today?

One share of HCWB stock can currently be purchased for approximately $2.06.

How much money does HCW Biologics make?

HCW Biologics (NASDAQ:HCWB) has a market capitalization of $73.89 million and generates $4.10 million in revenue each year.

How can I contact HCW Biologics?

The official website for the company is www.hcwbiologics.com. The company can be reached via phone at 954-842-2024, via email at mmcenroe@tiberend.com, or via fax at 954-842-2037.

This page (NASDAQ:HCWB) was last updated on 12/6/2022 by MarketBeat.com Staff